文章核心观点 - Project C U R E 与微软合作 利用微软技术栈提升运营效率 扩大其向发展中国家提供捐赠医疗物资的全球影响力 [1][3][6] 全球医疗资源缺口现状 - 全球超过45亿人 即超过一半人口 无法获得基本卫生服务 [1] - 在低收入国家 约80%的人口缺乏基本医疗保障 [1] - 医院缺乏基本物资 医生重复使用一次性设备 导致可预防的疾病和死亡 [1] Project C U R E 组织概况 - 公司成立于1987年 从车库起步 现已发展成为全球最大的捐赠医疗物资和服务提供商之一 [2][7] - 总部位于科罗拉多州丹佛市 在美国拥有7个分发中心 [7] - 通过全球超过35000名志愿者网络 向135个以上国家的医院和诊所提供可持续的医疗援助 [2][7] 与微软的技术合作细节 - 利用完整的微软技术栈 包括Dynamics 365 Power Platform Power BI和Microsoft Teams [3] - 将评估规划 财务跟踪 供应链管理 志愿者调度 捐赠者参与和项目协调整合到一个互联生态系统中 [4] - 手动工作量从约80%显著降低至约15% [4] - Power Platform自动化关键工作流 Power BI提供实时仪表板可视化影响 [4] - Microsoft Teams连接全球超过35000名志愿者 员工和医疗专业人员 实现安全协作 [5] 合作带来的效益 - 实现复杂项目的全流程可视性 实时跟踪财务 库存和运输数据 [5] - 增强了向捐赠者和合作伙伴的问责制 效率和透明度 [5] - 团队士气提升 更具创造力和活力 捐赠者因更清晰地了解资源去向而感到兴奋 [6]

Henry Schein Inc. (NYSE:HSIC) reported on Tuesday that its third-quarter adjusted earnings were $1.38, up 13.1% year over year, beating the consensus of $1.28.HSIC stock is showing exceptional strength. See the trading setup hereSales totaled $3.34 billion, surpassing the consensus estimate of $3.28 billion. Net sales increased 5.2% compared to the third quarter of 2024, reflecting 3.3% internal sales growth, 0.7% sales growth from acquisitions, and a 1.2% increase due to foreign currency exchange.Also Read ...

Nov 4, 2025 6:30 AM Eastern Standard Time InfuSystem Reports Third Quarter 2025 Financial Results Share Record Net Revenues of $36.5 million Representing 3% Growth from the Prior YearNet income of $2.3 million, up 25%Adjusted EBITDA (non-GAAP) of $8.3 million, up 6%Adjusted EBITDA (non-GAAP) margin expanded by 0.5% to 23%Year-to-Date Net Operating Cash Flow of $17.3 million, up 38%Stock Repurchases totaled $2.2 million during third quarterReaffirms Full-Year 2025 Guidance ROCHESTER HILLS, Mich.--(BUSINESS W ...

- Emil Lendof/WSJ Software company Navan plans to make its stock-market debut Thursday despite a government shutdown that has stalled other new listings. Navan priced its offering at $25 a share, valuing Navan at roughly $6.2 billion, and raised around $923 million for the company and selling shareholders. It is the biggest company so far to stage an initial public offering using a workaround provided by the Securities and Exchange Commission. Most Read from The Wall Street Journal The IPO market had b ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Medical and surgical products provider Medline has filed for an initial public offering in the U.S., the company said Tuesday. The planned listing, which Reuters reports could raise $5 billion at a $50 billion valuation, follows a six-month period in which the company grew sales almost 10% to reach $13.5 billion. Medline named multi-year preferred sup ...

MELBOURNE, Australia and PALM BEACH, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- CYIOS Corporation LLC (OTC: CYIO) (“CYIOS” or the “Company”), a Nevada-registered holding company focused on acquisitions, modernization and technology integration in the healthcare and medical supply sectors, today announced it has engaged Atlanta Capital Partners, LLC to lead a renewed investor relations strategy designed to expand CYIOS’s visibility and enhance communication across the investment community. Atlanta Capital Partn ...

Oct 22, 2025 6:30 AM Eastern Daylight Time Henry Schein to Participate in Upcoming Investor Conferences in November Share MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., (Nasdaq: HSIC) the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in November: Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be av ...

MELBOURNE, Australia and PALM BEACH, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CYIOS Corporation (OTC: CYIO) today announced that David Lewis has stepped down from his roles with CYIOS, and as part of this transition, he has voluntarily agreed to return 16,560 Series D Preferred Shares to the Company, and cancel all outstanding salary and loan obligations. This decisive step strengthens the company’s balance sheet, simplifies its capital structure, and positions CYIOS for its next stage of growth. We wish Dav ...

事件概述 - 一家股东权益律师事务所正代表长期股东对West Pharmaceutical Services Inc进行调查 调查涉及公司董事会是否违反了对公司的信托责任 [1] - 调查源于一项于2025年6月20日提起的集体诉讼 诉讼的类别期间为2023年2月16日至2025年2月12日 [1] 指控内容 - 指控称公司在类别期间内未能披露其高利润的高价值产品组合正经历显著且持续的库存削减 而非其声称的暂时性COVID相关产品去库存 [6] - 公司的SmartDose设备由于运营效率低下 对公司的利润率产生高度稀释 而非其宣称的高利润增长产品定位 [6] - 这些利润率压力导致了成本高昂的重组活动风险 包括退出与长期客户的连续血糖监测合同 [6] - 因此 公司关于其业务、运营和前景的正面陈述存在重大虚假和/或误导性 或缺乏合理依据 [6] 股价影响 - 真相通过一系列披露被揭示 最终在2025年2月13日 公司发布了极其疲软的2025年营收和盈利预测 [6] - 导致股价当日下跌每股123.17美元 跌幅达38% 收盘于每股199.11美元 [6] 业绩预测与业务调整 - 公司将令人失望的业绩指引部分归因于合同制造业务的阻力 包括失去两位主要连续血糖监测客户 因公司决定不再参与后续合作 因其财务门槛无法达成 [6] - 公司透露其SmartDose可穿戴注射器设备在2025年将是"利润率稀释的" 并将采取措施改善其经济效益 所有选项都在考虑之中 [6]

交易概述 - 欧文斯与迈纳公司已达成协议 将其医疗产品与服务部门出售给私募股权公司Platinum Equity 交易金额为3.75亿美元 [8] - 该交易预计将于2025年底完成 完成后公司将专注于直接面向患者和家庭健康机构的医疗用品配送业务 [8] - 欧文斯与迈纳公司将保留所出售业务5%的股份 若Platinum Equity未来转售该部门 公司可能获得部分收益分成 [6] 出售业务部门详情 - 被出售的业务部门主要为医疗保健提供商提供感染预防医疗用品和服务 [4] - 该部门去年产生的净收入为80亿美元 而公司保留的患者直接业务收入为27亿美元 [4] - 被剥离业务去年的营业利润为5300万美元 远低于患者直接业务2.6亿美元的营业利润 [4] - 公司于2024年2月首次披露该部门待售 并于8月将其在财务报表中列为终止经营业务 [3] 战略重点与财务规划 - 出售该部门后 公司战略重点将集中在患者直接业务上 该业务被认为具有更高的增长潜力和利润率 [4] - 交易所得资金将主要用于偿还债务 公司对大规模交易持谨慎态度 但仍对小型补强收购持开放态度 [6] - 公司去年曾试图以13.6亿美元收购Rotech Healthcare Holdings以加强患者直接业务 但该交易因联邦贸易委员会调查于6月终止 [5]